Xilio Therapeutics, Inc.
XLONasdaqCIK 1840233HealthcareFiscal year ends Dec 31
Reports and events: 100 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1211:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-345759 |
| 2026-08-1211:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-345753 |
| 2026-06-1220:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269358 |
| 2026-05-1211:40 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-218200 |
| 2026-05-1211:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218194 |
| 2026-04-2821:02 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001193125-26-187642 |
| 2026-04-1611:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-157940 |
| 2026-03-2311:40 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-118550 |
| 2026-03-2311:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-118544 |
| 2026-03-1212:34 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-103150 |
| 2026-03-0912:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097603 |
| 2026-02-2412:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-065234 |
| 2026-02-1221:51 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-048942 |
| 2026-01-2612:30 ET | DEF 14A | Proxy statementPeriod 2026-02-23 | 0001193125-26-021691 |
| 2026-01-0813:42 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-007063 |
| 2026-01-0513:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-001580 |
| 2025-11-2521:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-297165 |
| 2025-11-1312:40 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-278837 |
| 2025-11-1312:35 ET | 8-K | 2.02 Results of operations | 0001193125-25-278835 |
| 2025-11-0714:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-271189 |
| 2025-10-2011:39 ET | DEF 14A | Proxy statementPeriod 2025-11-21 | 0001193125-25-243037 |
| 2025-10-0311:30 ET | 8-K | 3.01 Delisting notice | 0001193125-25-229231 |
| 2025-09-0911:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011949 |
| 2025-08-2820:05 ET | 8-K | 3.01 Delisting notice | 0001558370-25-011802 |
| 2025-08-1412:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011477 |
| 2025-08-1411:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011473 |
| 2025-06-1220:30 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-008571 |
| 2025-06-1020:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-25-008512 |
| 2025-06-0311:38 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-133773 |
| 2025-06-0210:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132710 |
| 2025-05-0820:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006996 |
| 2025-05-0811:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006852 |
| 2025-04-2820:30 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001558370-25-005689 |
| 2025-04-0820:31 ET | 8-K | 3.01 Delisting notice | 0001558370-25-004599 |
| 2025-03-1112:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-051532 |
| 2025-03-1112:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002640 |
| 2025-03-1111:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-051441 |
| 2025-02-1212:36 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000823 |
| 2025-01-2122:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000291 |
| 2024-12-1912:45 ET | 8-K | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-016372 |
| 2024-11-0714:25 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014775 |
| 2024-11-0714:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-014773 |
| 2024-09-1320:16 ET | 8-K | 3.01 Delisting notice | 0001558370-24-012775 |
| 2024-08-0811:51 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011471 |
| 2024-08-0811:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011470 |
| 2024-06-1720:06 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-009247 |
| 2024-06-1320:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-24-009138 |
| 2024-05-1412:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-008068 |
| 2024-05-1411:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-008063 |
| 2024-04-2520:05 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001558370-24-005762 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.